A study recently conducted showed those who participated in clinical trials were likely to live longer. In an article at Reuters by Trevor Stokes, they look at this and wonder whether or not it was the treatment or patients being active in their healthcare that was the result of this finding. They studied patients from the California Cancer Registry between 2002 and 2006 and looked at the survival rates of 550,000 people. For those who were enrolled in clinical trials, they found that 26% decrease in chance of death for those with lung, colon and breast cancer. Traditionally, clinical trial enrollment rates are very low. However, this article points out that not only is it the innovative treatments people are benefiting from but also the extra care from doctors who know how to dive into the resources that medicine has to offer.
So where did Stokes see room for enrollment improvement? Look for and enroll patients that are outside the typical patient profile to those who are older, under-insured and are at more advanced disease states. Do you agree?
This April at Partnerships in Clinical Trials, we focus on many aspects of patient enrollment. In the session Innovative Tools and Strategies to Optimize Site Selection and Performance Merck and IMS Health look at the opportunities to work with sites to improve enrollment performance, predictably deliver enrollment time lines and reduce study costs as it relates to patients. For more information on this session and the rest of the program, download the agenda. If you'd like to join us in Orlando, as a reader of this blog when you register to join us and mention code XP1800BLOG, you'll save 10% off the standard rate!
What's your opinion? Why do you think patients in clinical trials have a longer life rate than those who do not enroll?
Drug Development in Alzheimer’s Disease: Reasons to Remain Optimistic
Date: Thursday, September 18, 2014
Time: 10:00 AM - 11:00 AM EDT
Mention proirity code XP2000W1BLOG
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is supported by a number of industry events:
Would you like to guest blog on our site? Or send us feedback? Send an email to firstname.lastname@example.org.